Scottish researchers have made a breakthrough in the treatment of Parkinson's disease which could result in better treatments which could prevent it developing, or possibly halt or reverse the progress of the disease in those already showing symptoms.
Parkinson's is a progressive neurological disorder caused by cell death in part of the brain, with physically disabling effects and no known cure. It affects around 145,000 people in the UK.
But work carried out by scientists at the University of Dundee has confirmed that a cellular pathway that normally protects the brain from damage is compromised in Parkinson's patients.
A team headed by Professor Miratul Muqit, sought out patients around the world with a rare genetic mutation in an attempt to confirm a suspected cause of the debilitating disease which commonly affects people aged 60 or over.
Experiments on mice had indicated a mutation affecting a gene called PINK1 and another called Parkin are critical to helping the body shut down cells in the brain when they go wrong. Sensing when cells are damaged PINK1 is able to switch on the Parkin Gene, which produces enzymes, ultimately preventing further deterioration.
However it was thought that this process is failing in Parkinson's patients.
Professor Muqit, consultant Neurologist at the University’s cutting edge MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), and his team were able to confirm this by locating patients with rare mutations in the Parkin gene that precisely disrupt the ability of PINK1 to switch the Parkin enzyme on.
He said: “We did not know whether this pathway really was key in the development of Parkinson’s.
“The probability of finding rare patients with the critical mutation to test in the lab was as low as 1 in 3 billion so we are grateful to our collaborators who helped identify these rare patients who have helped us finally answer this question.
“There is currently great interest to directly target PINK1 and Parkin as a potential therapy against Parkinson’s and this study strongly backs the rationale of this approach.”
Together with researchers at the University of Helsinki, the team tracked down a Finnish patient who had developed early-onset Parkinson’s and were able to obtain cells from the patient that revealed that the activity of the Parkin enzyme was defective thereby confirming this as a cause for their Parkinson’s.
A second patient in the United States was identified from the Progressive Parkinson’s Markers Initiative study, coordinated by the Michael J Fox Foundation.
Professor Dario Alessi, Director of the MRC-PPU, “This is a wonderful and high-quality study that provides crystal clear fundamental information on how mutations in PINK1 and Parkin genes cause Parkinson’s disease. This is the result of six years of painstaking research by Professor Muqit and his lab and lays the groundwork for the development of new treatments for Parkinson’s disease.”
Annie Macleod, Scotland Director at Parkinson's UK, said: "This latest breakthrough puts research in Scotland at the centre of a global network of scientists working to unravel the mysteries behind Parkinson's and drive towards a cure.
"For people with Parkinson's this research opens the door for potential drug treatments that could prevent, halt and possibly reverse the progression of Parkinson's symptoms."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereLast Updated:
Report this comment Cancel